Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels-Reference-Cited by-同舟云学术

Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels

Published:2016-02 Issue: Volume:74 Page:37-42
ISSN:0531-5565
Container-title:Experimental Gerontology
language:en
Short-container-title:Experimental Gerontology

Author:

Zhao Jiahui,Cheng Qingli,Ye Ping,Yang Guang,Liu Sheng,Ao Qiangguo,Liu Yang,Hu Yazuo

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Genetics,Molecular Biology,Aging,Biochemistry

Reference21 articles.

1. The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: a subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study;Athyros;J. Clin. Pathol.,2004

2. Interplay between statins and PPARs in improving cardiovascular outcome: a double-edged sword?;Balakumar;Br. J. Pharmacol.,2012

3. Peroxisome proliferator-activated receptors and inflammation;Belvisi;Pharmacol. Ther.,2005

4. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease;Bianchi;Am. J. Kidney Dis.,2003

5. Aging and the Disposition and Toxicity of Mercury in Rats.;Bridges;Exp Gerontol,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the bidirectional role of MMP9: A key player in kidney injury;Cellular Signalling;2024-10

2. TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity;European Journal of Pharmacology;2023-05

3. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis;Ageing Research Reviews;2023-03

4. Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases;Critical Reviews in Food Science and Nutrition;2022-09-08

5. Angiotensin II receptor blocker and statin combination therapy associated with higher skeletal muscle index in patients with cardiovascular disease: A retrospective study;Journal of Clinical Pharmacy and Therapeutics;2021-10-20